ScoreWhy is ANG Lifesciences India Ltd ?
1
Weak Long Term Fundamental Strength with a -155.03% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 79.39 times
- The company has reported losses. Due to this company has reported negative ROE
2
Risky - Negative Operating Profits
- The company has recorded a negative EBIT of Rs. -5.64 cr
- Over the past year, while the stock has generated a return of 2.51%, its profits have risen by 10.6%
- The stock is trading risky as compared to its average historical valuations
3
44.88% of Promoter Shares are Pledged
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is ANG Lifesciences for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
ANG Lifesciences
2.51%
0.05
55.20%
Sensex
-5.6%
-0.42
13.26%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-28.45%
EBIT Growth (5y)
-155.03%
EBIT to Interest (avg)
1.13
Debt to EBITDA (avg)
14.58
Net Debt to Equity (avg)
1.43
Sales to Capital Employed (avg)
1.11
Tax Ratio
14.85%
Dividend Payout Ratio
0
Pledged Shares
44.88%
Institutional Holding
0
ROCE (avg)
4.20%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
0.73
EV to EBIT
-20.22
EV to EBITDA
114.06
EV to Capital Employed
0.89
EV to Sales
1.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.39%
ROE (Latest)
-20.97%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 1.22 times
NET SALES(Q)
At Rs 23.50 cr has Grown at 39.71%
PBDIT(Q)
Highest at Rs 2.67 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 11.36%
PBT LESS OI(Q)
Highest at Rs -1.27 cr.
PAT(Q)
Highest at Rs -1.38 cr.
EPS(Q)
Highest at Rs -1.06
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for ANG Lifesciences
Operating Profit to Interest - Quarterly
Highest at 1.22 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
At Rs 23.50 cr has Grown at 39.71%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 2.67 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 11.36%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs -1.27 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs -1.38 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs -1.06
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
